What precautions can be taken to prevent tigecycline overdose fatalities?

What are the warning signs of tigecycline overdose?

Tigecycline is an antibiotic approved for the treatment of certain infections, but it can cause serious side effects, including overdose fatalities [1]. The FDA issued a warning stating that tigecycline should not be used for patients with mild, moderate, or severe infections due to its increased risk of adverse effects [2]. Common warning signs of tigecycline overdose include:

* Abdominal pain

* Diarrhea

* Dizziness

* Headache

* Increased alanine transaminase (ALT) levels

* Increased aspartate transaminase (AST) levels

* Increased creatine kinase (CK) levels

* Nausea

* Pancytopenia

* Thrombocytopenia

How can healthcare providers prevent tigecycline overdose fatalities?

Healthcare providers should carefully select patients for tigecycline therapy and monitor them closely for signs of overdose [3]. Tigecycline should only be used in patients with severe infections, such as abdominal infections that are not responding to other treatments, and under close monitoring of liver function and electrolyte balance [2]. If signs of overdose occur, healthcare providers should immediately stop tigecycline therapy and seek medical attention.

What can patients do to prevent tigecycline overdose?

Patients taking tigecycline should monitor their health closely and seek medical attention immediately if they experience any of the warning signs of overdose [3]. Additionally, patients should:

* Take their medication exactly as prescribed by their healthcare provider

* Report any signs of overdose or adverse effects to their healthcare provider

* Follow up with their healthcare provider as recommended

When will the patent for tigecycline expire?

The patent for tigecycline, sold under the brand name Tygacil, expires in 2026 [4]. When the patent expires, generic versions of the medication become available, which can help to reduce costs and increase access to the medication. However, patients should always follow the instructions of their healthcare provider when taking medication.

Sources

[1] "Tigecycline." MedlinePlus, U.S. National Library of Medicine, www.medlineplus.gov/druginfo/meds/a606007.html.
[2] Food and Drug Administration. “FDA Approves Tygacil for the Treatment of Abdominal Infections.” Press Release, 14 Sept 2005.
[4] Generic and Brand Drug Applications, DrugPatentWatch.com https://www.drugpatentwatch.com/drug/14374
[5] "FDA Approves Tygacil." Press Release. 14 sept 2005, www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108349.htm.